Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2010, Article ID 616580, 5 pages
http://dx.doi.org/10.1155/2010/616580
Case Report

Medullary Thyroid Carcinoma with Micronodular Lung Metastases: A Case Report with an Emphasis on the Imaging Findings

Department of Radiology, Rio de Janeiro Federal University, Rio de Janeiro, CEP 21941.913, Brazil

Received 4 February 2010; Revised 18 March 2010; Accepted 22 March 2010

Academic Editor: Christian A. Koch

Copyright © 2010 Nina Ventura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Leboulleux, E. Baudin, J.-P. Travagli, and M. Schlumberger, “Medullary thyroid carcinoma,” Clinical Endocrinology, vol. 61, no. 3, pp. 299–310, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. H. Yanardag, C. Tetikkurt, and S. Tetikkurt, “Synchronous lung and liver metastases from medullary thyroid carcinoma,” Canadian Respiratory Journal, vol. 10, no. 1, pp. 39–41, 2003. View at Google Scholar · View at Scopus
  3. D. Giuffrida and H. Gharib, “Current diagnosis and management of medullary thyroid carcinoma,” Annals of Oncology, vol. 9, no. 7, pp. 695–701, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. W. W. Hung, C.-S. Wang, K.-B. Tsai, F. Ou-Yang, S.-J. Shin, and P.-J. Hsiao, “Medullary thyroid carcinoma with poor differentiation and atypical radiographic pattern of metastasis,” Pathology International, vol. 59, no. 9, pp. 660–663, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M.-H. Hsieh, Y.-L. Hsiao, and T.-C. Chang, “Fine needle aspiration cytology stained with riu's method in quicker diagnosis of medullary thyroid carcinoma,” Journal of the Formosan Medical Association, vol. 106, no. 9, pp. 728–735, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Nashed, S. V. Sakpal, S. Cherneykin, and R. S. Chamberlain, “Medullary thyroid carcinoma metastatic to skin ,” Journal of Cutaneous Pathology. In press. View at Publisher · View at Google Scholar · View at PubMed
  7. K. Afshar, R. Alalawi, and C. T. Boylen, “Micronodular radiographic pulmonary pattern in metastatic medullary thyroid carcinoma,” Journal of the National Medical Association, vol. 99, no. 5, pp. 575–577, 2007. View at Google Scholar · View at Scopus
  8. P. Chariot, A. Feliz, and I. Monnet, “Miliary opacities diagnosed as lung metastases of a thyroid carcinoma after 13 years of stability,” Chest, vol. 104, no. 3, pp. 981–982, 1993. View at Google Scholar · View at Scopus
  9. M. Schlumberger, F. Carlomagno, E. Baudin, J. M. Bidart, and M. Santoro, “New therapeutic approaches to treat medullary thyroid carcinoma,” Nature Clinical Practice Endocrinology and Metabolism, vol. 4, no. 1, pp. 22–32, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. G. W. Randolph and D. Maniar, “Medullary carcinoma of the thyroid,” Cancer Control, vol. 7, no. 3, pp. 253–261, 2000. View at Google Scholar · View at Scopus
  11. E. Kebebew, P. H. G. Ituarte, A. E. Siperstein, Q.-Y. Duh, and O. H. Clark, “Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems,” Cancer, vol. 88, no. 5, pp. 1139–1148, 2000. View at Google Scholar · View at Scopus
  12. P. A. Treseler and O. H. Clark, “Prognostic factors in thyroid carcinoma,” Surgical Oncology Clinics of North America, vol. 6, no. 3, pp. 555–598, 1997. View at Google Scholar · View at Scopus
  13. J. Brierley, R. Tsang, W. J. Simpson, M. Gospodarowicz, S. Sutcliffe, and T. Panzarella, “Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control,” Thyroid, vol. 6, no. 4, pp. 305–310, 1996. View at Google Scholar · View at Scopus
  14. M. E. Dottorini, A. Assi, M. Sironi, G. Sangalli, G. Spreafico, and L. Colombo, “Multivariate analysis of patients with medullary thyroid carcinoma: prognostic significance and impact on treatment of clinical and pathologic variables,” Cancer, vol. 77, no. 8, pp. 1556–1565, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Dorairajan, D. Siddharth, and S. Kanna, “Review analysis of medullary carcinoma of the thyroid: a 15-year Indian experience,” International Surgery, vol. 91, no. 3, pp. 162–167, 2006. View at Google Scholar · View at Scopus
  16. R. T. Kloos, C. Eng, D. B. Evans et al., “Medullary thyroid cancer: management guidelines of the American Thyroid Association,” Thyroid, vol. 19, no. 6, pp. 565–612, 2009. View at Google Scholar
  17. M. F. Saad, N. G. Ordonez, J. J. Guido, and N. A. Samaan, “The prognostic value of calcitonin immunostaining in medullary carcinoma of the thyroid,” Journal of Clinical Endocrinology and Metabolism, vol. 59, no. 5, pp. 850–856, 1984. View at Google Scholar · View at Scopus
  18. B. Franc, M. Rosenberg-Bourgin, B. Caillou et al., “Medullary thyroid carcinoma: search for histological predictors of survival (109 proband cases analysis),” Human Pathology, vol. 29, no. 10, pp. 1078–1084, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. J. M. Ruppert, J. C. Eggleston, A. deBustros, and S. B. Baylin, “Disseminated calcitonin-poor medullary thyroid carcinoma in a patient with calcitonin-rich primary tumor,” American Journal of Surgical Pathology, vol. 10, no. 7, pp. 513–518, 1986. View at Google Scholar · View at Scopus
  20. A. L. Giraudet, D. Vanel, S. Leboulleux et al., “Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 11, pp. 4185–4190, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. D. W. Ball, S. B. Baylin, and A. C. de Bustros, “Medullary thyroid carcinoma,” in Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, L. E. Braverman and R. E. Utiger, Eds., pp. 930–943, Lippincott, Williams & Wilkins, Philadelphia, Pa, USA, 8th edition, 2000. View at Google Scholar
  22. R. F. Gagel and S. J. Marx, “Multiple endocrine neoplasia,” in Williams Textbook of Endocrinology, P. R. Larsen, H. M. Kronenberg, S. Melmed, and K. S. Plonsky, Eds., pp. 1717–1762, Philadelphia, Pa, USA, W.B. Saunders, 10th edition, 2002. View at Google Scholar
  23. G. Pellegriti, S. Leboulleux, E. Baudin et al., “Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging,” British Journal of Cancer, vol. 88, no. 10, pp. 1537–1542, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. A. Machens, U. Schneyer, H. J. Holzhausen, and H. Dralle, “Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 4, pp. 2029–2034, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. G. Mendelsohn, S. A. Wells Jr., and S. B. Baylin, “Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease,” Cancer, vol. 54, no. 4, pp. 657–662, 1984. View at Google Scholar · View at Scopus
  26. B. Gorman, J. W. Charboneau, E. M. James et al., “Medullary thyroid carcinoma: role of high-resolution US,” Radiology, vol. 162, no. 1, part 1, pp. 147–150, 1987. View at Google Scholar
  27. G. Mazoyer, J. F. Cordier, J. M. Zabern et al., “Pulmonary metastases in medullary cancers of the thyroid. Study of 4 cases. Originality of the lymphangitic form with amyloid stroma,” Revue des Maladies Respiratoires, vol. 3, no. 3, pp. 139–143, 1986. View at Google Scholar · View at Scopus
  28. J. M. Jimenez, S. O. Casey, M. Citron, and A. Khan, “Calcified pulmonary metastases from medullary carcinoma of the thyroid,” Computerized Medical Imaging and Graphics, vol. 19, no. 4, pp. 325–328, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. C. H. McDonnell III, E. K. Fishman, and E. A. Zerhouni, “CT demonstration of calcified liver metastases in medullary thyroid carcinoma,” Journal of Computer Assisted Tomography, vol. 10, no. 6, pp. 976–978, 1986. View at Google Scholar
  30. K. Brandt-Mainz, S. P. Müller, R. Görges, B. Saller, and A. Bockisch, “The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer,” European Journal of Nuclear Medicine, vol. 27, no. 5, pp. 490–496, 2000. View at Google Scholar · View at Scopus
  31. N. D. Charkes, R. A. Vitti, and K. Brooks, “Thallium-201 SPECT increases detectability of thyroid cancer metastases,” Journal of Nuclear Medicine, vol. 31, no. 2, pp. 147–153, 1990. View at Google Scholar · View at Scopus
  32. B. G. Conry, N. D. Papathanasiou, V. Prakash et al., “Comparison of G68a-DOTATATE and F18- fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 1, pp. 49–57, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. J.-F. Chatal, L. Campion, F. Kraeber-Bodéré et al., “Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French endocrine tumor group,” Journal of Clinical Oncology, vol. 24, no. 11, pp. 1705–1711, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus